Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Gastrointestinal 1Dermatologic 1

Conditions

Carcinoma, Hepatocellular 63Colorectal Neoplasms 30Biliary Tract Neoplasms 29Cholangiocarcinoma 27Pancreatic Neoplasms 26Liver Neoplasms 18Stomach Neoplasms 13Esophageal Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Breast Neoplasms 10Gallbladder Neoplasms 9Adenocarcinoma Of Esophagus 9Neoplasm Metastasis 8Esophageal Squamous Cell Carcinoma 8Ovarian Neoplasms 7Melanoma 7Squamous Cell Carcinoma of Head and Neck 6Small Cell Lung Carcinoma 6Carcinoma, Renal Cell 6Carcinoma 6Bile Duct Neoplasms 6Triple Negative Breast Neoplasms 5Rectal Neoplasms 5Prostatic Neoplasms 5Colonic Neoplasms 5Uterine Cervical Neoplasms 4Lung Neoplasms 4Diabetes Mellitus, Insulin-Dependent, 12 4Adenocarcinoma 4Neoplasms 3

Interventions

pembrolizumab 44Fluorouracil 16Cisplatin 15Oxaliplatin 13Capecitabine 11Paclitaxel 10lenvatinib 8Leucovorin 8Irinotecan 6Docetaxel 6trifluridine tipiracil drug combination 3regorafenib 3Saline Solution 3Levoleucovorin 3Gemcitabine 3Bevacizumab 3patritumab deruxtecan 2Trastuzumab 2S 1 (combination) 2Radiotherapy 2Cetuximab 2Carboplatin 2zanidatamab 1vicriviroc 1tremelimumab 1tislelizumab 1tipiracil 1spartalizumab 1sinoporphyrin sodium 1ribociclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body × durvalumab × Gastrointestinal × Clear all
NCT02735239 2024-03-22

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer

Ludwig Institute for Cancer Research

Phase 1/2 Completed
73 enrolled 18 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡